On May 9, SciLifeLab arranged a lunch seminar on Cutting-Edge Technologies in Precision Cancer Medicine during the three-day Keystone Symposia taking place in Stockholm. The conference was also co-organized by SciLifeLab.
The seminar featured several researchers and facilities from SciLifeLab, highlighting large-scale sequencing efforts carried out in different cancer types, which have paved the way for the incorporation of next-generation sequencing-based approaches into routine clinical diagnostics and every-day patient care. To complement the presentations, the seminar also included a lunch mingle to promote new connections and collaborations, as well as to present SciLifeLab to the participating group of around 100 international researchers.
Chair: Valtteri Wirta, Head of unit, Clinical Genomics, SciLifeLab
Olli, Kallioniemi, Director, SciLifeLab
Welcome and introduction to SciLifeLab
Linn Fagerberg, KTH Royal Institute of Technology, SciLifeLab
Wellness profiling and the Human Protein Atlas
Janne Lehtiö, Platform Director, Chemical Proteomics & Proteogenomics platform, SciLifeLab
Coupling cancer genotype with molecular phenotype by proteogenomics
Per Arvidsson, Platform Director, Drug Discovery and Development platform, SciLifeLab
Turning academic cancer research projects into translational drug discovery programs
Richard Rosenquist Brandell, Dept. of Molecular Medicine and Surgery, Karolinska Institutet
Genomic Medicine Sweden – a national precision medicine initiative
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.